Guidelines for »patient self-management of oral anti-coagulation«;Leitlinien »gerinnungsselbstmanagement«

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 12, 2001, Pages 346-351

  Bernardo, A ^a   Voller H ^a  

^a Klin fur Kardiale/Psychosomatische   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; DEVICE; LONG TERM CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; PROTHROMBIN TIME; QUALITY ADJUSTED LIFE YEAR; SELF CARE; SELF MONITORING; TREATMENT INDICATION; ARTICLE; DRUG SELF ADMINISTRATION; HUMAN; ORAL DRUG ADMINISTRATION; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HUMANS; SELF ADMINISTRATION; THROMBOEMBOLISM;

EID: 18044399380     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12092     Document Type: Conference Paper

References (30)

1. Evaluation of a portable prothrombin time monitor for home use by patiens who require long-term oral anticoagulant therapy
2. Long-term patient self-management of oral anticoagulation
3. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management
4. Optimierung der langzeit-antikoagulation durch patienten-selbstmanagement?
5. Prevention of major bleeding in older patients treated with warfarin: Results of a randomised trial
6. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
7. Patienten-selbstkontrolle der oralen antikoagulation mit CoaguChek
8. Optimal oral anticoagulation therapy in patients with mechanical heart valves
9. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic
10. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomised cross-over comparison
11. Bleeding and thromboembolism during anticoagulation therapy: A population-based study in Rochester, Minnesota
12. Self-monitoring of prothrombin time using a portable coagulation monitor
13. Self management of oral anticoagulant therapy after heart valve replacement
14. Clinical outcome of self management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis
15. Evaluation of CoaguChek INR results from venous whole blood versus capillary whole blood
16. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease
17. Accuracy of laboratory and portable monitor international normalized ratio determinations
18. ESCAT - Early self-controlled anticoagulation trial
19. Anticoagulation clinics and patient-selftesting for patients on chronic warfarin therapy: A cost-effectiveness analysis
20. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
21. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor
22. Selbstkontrolle der oralen antikoagulation: Standortbestimmung
23. Bleeding complications of oral anticoagulation treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy
24. A structured teaching and self-management program for patients receiving oral anticoagulation. A randomised controlled trial
25. Imprecision of INR self-testing compared to laboratory testing
26. Cost-effectiveness of self-managed anticoagulant therapy in Germany
27. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation
28. Home prothrombin time monitoring after the initiation of warfarin therapy; a randomised prospective study